Synercid

Q: What is synercid used for?

<p>This medication is a combination of 2 <a href="https://www.withpower.com/clinical-trials/antibiotics">antibiotics</a>. It is used to treat certain serious bacterial infections that have not responded to treatment with other antibiotics (resistant infections). This medication belongs to the class of antibiotics known as streptogramins.</p>

Bacterial Infections, Urinary Tract Infection (UTI), Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

Treatment

3 FDA approvals

9 Active Studies for Synercid

Treatment for

Bacterial Infections

What is Synercid

QuinupristinThe Generic name of this drug

Treatment SummaryDalfopristin is a combination of two antibiotics used to treat infections caused by staphylococcus bacteria and the vancomycin-resistant Enterococcus faecium bacteria. It does not work against Enterococcus faecalis infections. Dalfopristin blocks the first stage of protein production in the bacterial ribosome and quinupristin blocks the last stage of protein production.

Synercidis the brand name

Synercid Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Synercid

Quinupristin

1999

Approved as Treatment by the FDA

Quinupristin, otherwise called Synercid, is approved by the FDA for 3 uses which include Bacterial Infections and Urinary Tract Infection (UTI) .

Bacterial Infections

Used to treat Bacterial Infections in combination with Dalfopristin

Urinary Tract Infection (UTI)

Used to treat Bacterial Infections in combination with Dalfopristin

Bacterial Infections

Used to treat complicated Skin and subcutaneous tissue bacterial infection in combination with Dalfopristin

Effectiveness

How Synercid Affects PatientsDalfopristin is a type of antibiotic medicine derived from pristinamycin IIA, which is used to treat certain bacterial infections.

How Synercid works in the bodyDalfopristin works on bacterial cells by blocking the process of making proteins. It stops the early stages of protein creation and prevents bacteria from growing.

When to interrupt dosage

The recommended dosage of Synercid is reliant upon the diagnosed condition, including Urinary Tract Infection (UTI), Bacterial Infections and Methicillin Resistant Staphylococcus Aureus Infection (MRSA). The measure of dosage fluctuates depending on the technique of delivery (e.g. Injection or Injection - Intravenous) specified in the table below.

Condition

Dosage

Administration

Bacterial Infections

, 150.0 mg, 150.0 mg/mL, 180.0 mg/mL

, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Injection, Injection - Intravenous

Urinary Tract Infection (UTI)

, 150.0 mg, 150.0 mg/mL, 180.0 mg/mL

Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

, 150.0 mg, 150.0 mg/mL, 180.0 mg/mL

Warnings

Synercid Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Synercid.

Common Synercid Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Quinupristin.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Quinupristin.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Quinupristin.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Quinupristin.

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Quinupristin.

Synercid Novel Uses: Which Conditions Have a Clinical Trial Featuring Synercid?

28 active clinical trials are currently underway to investigate the potential of Synercid in mitigating Bacterial Infections, Methicillin Resistant Staphylococcus Aureus Infection (MRSA) and Urinary Tract Infection (UTI).

Condition

Clinical Trials

Trial Phases

Urinary Tract Infection (UTI)

9 Actively Recruiting

Phase 1, Phase 3, Phase 4, Not Applicable

Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Patient Q&A Section about synercid

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is synercid used for?

"This medication is a combination of 2 antibiotics. It is used to treat certain serious bacterial infections that have not responded to treatment with other antibiotics (resistant infections). This medication belongs to the class of antibiotics known as streptogramins."

Answered by AI

Does synercid cover MRSA?

"This study evaluated the use of Synercid and vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections. Five cases were included in the study. The results showed that the combined use of Synercid and vancomycin was effective in treating these infections."

Answered by AI

What does Synercid cover?

"Quinupristin and dalfopristin, sold under the brand name Synercid, are antibiotics used to treat bacterial infections. They work by fighting bacteria in the body."

Answered by AI

What is the generic name for synercid?

"Synercid is a medication that is used to treat bacterial infections. The typical dosage is two tablets three times per day. However, the dosage may be different for different people. Some common side effects include headache, dizziness, and nausea."

Answered by AI

Clinical Trials for Synercid

Have you considered Synercid clinical trials? We made a collection of clinical trials featuring Synercid, we think they might fit your search criteria.